Erik Stroes

31PUBLICATIONS
150CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Medical biochemistry - lipidsCardiovascular medicine and haematology not elsewhere classifiedEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Mar 30, 2026
Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

|Nov 10, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.

Nicholas A Marston, Brian A Bergmark, Veronica J Alexander

|Mar 05, 2025
Challenges in achieving LDL cholesterol targets and novel approaches to lipid lowering.

Waqas A Malick, Daein Choi, Anne Langsted

|Feb 06, 2025
The role of systemic inflammation in remnant cholesterol-associated cardiovascular risk: insights from the EPIC-Norfolk study.

Jordan M Kraaijenhof, Marije J Kerkvliet, Nick S Nurmohamed

|Jan 25, 2024
Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation.

Kim E Dzobo, Arjen J Cupido, Barend M Mol

|Nov 10, 2023
Association Between Self-Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension.

Shirin Ibrahim, Nick S Nurmohamed, Didier Collard

Pageof 6

Frequent Collaborators

8 joint publications

Nick S Nurmohamed

6 joint publications

Jordan M Kraaijenhof

6 joint publications

Laurens F Reeskamp

6 joint publications

Jeffrey Kroon